GenMont Biotech (Taiwan) Today
| 3164 Stock | TWD 20.30 0.05 0.25% |
Performance0 of 100
| Odds Of DistressLess than 9
|
GenMont Biotech is selling for under 20.30 as of the 1st of December 2024; that is 0.25 percent increase since the beginning of the trading day. The stock's lowest day price was 20.3. GenMont Biotech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for GenMont Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 12th of December 2022 and ending today, the 1st of December 2024. Click here to learn more.
GenMont Biotech Incorporation engages in the research, development, and production of functional probiotics in Taiwan. The company was founded in 2000 and is based in Tainan, Taiwan. GENMONT BIOTECH operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.. The company has 86.37 M outstanding shares. More on GenMont Biotech
Moving against GenMont Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
GenMont Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. GenMont Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding GenMont Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
GenMont Biotech (3164) is traded on Taiwan Stock Exchange in Taiwan and employs 13 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GenMont Biotech's market, we take the total number of its shares issued and multiply it by GenMont Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GenMont Biotech operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 86.37 M outstanding shares.
GenMont Biotech has accumulated about 999.04 M in cash with 111.66 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.24.
Check GenMont Biotech Probability Of Bankruptcy
Ownership AllocationGenMont Biotech has a total of 86.37 Million outstanding shares. GenMont Biotech secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GenMont Ownership Details
GenMont Biotech Risk Profiles
Although GenMont Biotech's alpha and beta are two of the key measurements used to evaluate GenMont Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.639 | |||
| Standard Deviation | 0.8739 | |||
| Variance | 0.7637 | |||
| Risk Adjusted Performance | (0.21) |
GenMont Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in GenMont Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Additional Tools for GenMont Stock Analysis
When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.